Thursday, November 19, 2020 9:27:23 AM
Recent ADTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 08:15:07 PM
- Aditxt To Host Stakeholder Update and Q&A Session on Friday, October 11, 2024, at 11:30 AM Eastern Daylight Time • Business Wire • 10/09/2024 02:52:00 PM
- Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem • Business Wire • 10/08/2024 12:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/07/2024 01:23:41 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/07/2024 12:54:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:30:09 PM
- Aditxt Delivers Shareholder Update and 2024 Year-End Plan • Business Wire • 10/03/2024 12:15:00 PM
- Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on October 2, 2024 • Business Wire • 09/27/2024 12:15:00 PM
- Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt • Business Wire • 09/24/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 09:23:03 PM
- Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025 • Business Wire • 09/20/2024 12:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/16/2024 08:20:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/16/2024 04:15:14 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/11/2024 09:20:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 08:15:39 PM
- Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024 • Business Wire • 09/09/2024 12:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/06/2024 09:04:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/06/2024 08:16:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:09 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2024 01:22:30 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/05/2024 01:18:07 PM
- Aditxt Subsidiary Pearsanta Submits a Grant Application Seeking to Advance Clinical Trials for Mitomic® Prostate Test, Targeting Early Detection in High-Risk Patients • Business Wire • 09/04/2024 12:15:00 PM
- Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024 • Business Wire • 08/29/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 08:30:21 PM
- Aditxt’s Precision Health Subsidiary, Pearsanta, Appoints Christopher Mitton as President as it Seeks to Complete Clinical Validation Studies for its Mitomic® Endometriosis Test (MET™) and Mitomic® Prostate Test (MPT™) • Business Wire • 08/26/2024 12:15:00 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM